Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. TLTFF


Primary Symbol: V.TLT

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by CancerSlayeron Nov 22, 2024 2:05am
160 Views
Post# 36325325

RE:RE:RE:RE:RE:Next NR

RE:RE:RE:RE:RE:Next NR
rhodiumd wrote: I understand what you're trying to say but I wouldn't go as far as calling it "nice". Let's all keep in mind that there are very real people going through hell involved in those other trials. It's sad to think some patients could have gotten a better treatment just because a referring doctor got a visit from a lobbyist linked to big pharma. Let's just be grateful for the promising results TLT has been getting.


..."paradoxically beneficial" would have been a better choice of words.  As this tech gains more attention/acceptance as dictated by the science/results, more sound decision-making can take place, which is the goal.

<< Previous
Bullboard Posts
Next >>